GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tanvex BioPharma Inc (TPE:6541) » Definitions » Notes Receivable

Tanvex BioPharma (TPE:6541) Notes Receivable : NT$0.00 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Tanvex BioPharma Notes Receivable?

Tanvex BioPharma's Notes Receivable for the quarter that ended in Mar. 2025 was NT$0.00 Mil.


Tanvex BioPharma Notes Receivable Historical Data

The historical data trend for Tanvex BioPharma's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tanvex BioPharma Notes Receivable Chart

Tanvex BioPharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tanvex BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tanvex BioPharma Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Tanvex BioPharma Notes Receivable Related Terms

Thank you for viewing the detailed overview of Tanvex BioPharma's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tanvex BioPharma Business Description

Traded in Other Exchanges
N/A
Address
No. 376, Ren\'ai Road, Section 4, 13th Floor-1, Da\'an District, Taipei, TWN, 106
Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products and contract development and manufacturing of biological medicine. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States.

Tanvex BioPharma Headlines

No Headlines